CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities
Net income (loss)	$ 1,997,000	$ (7,661,000)	$ (11,396,000)
Net income from discontinued operations, net of tax	18,667,000	17,178,000	1,578,000
Net loss from continuing operations	(16,670,000)	(24,839,000)	(12,974,000)
Adjustments to reconcile net income (loss) from continuing operations to cash used in operating activities:
Stock-based compensation expense	1,574,000	862,000	656,000
Depreciation and amortization	17,102,000	5,724,000	5,312,000
Provision for bad debt	242,000	826,000	239,000
Loss (gain) on commodity derivative contracts	87,978,000	2,258,000	(3,477,000)
Provision for environment clean up	1,428,000	0
Gain on forgiveness of debt	0	(4,222,000)	0
Net cash settlement on commodity derivatives	(92,556,000)	(2,436,000)	4,253,000
Loss on sale of assets	220,000	64,000	125,000
Loss on assets impairment	0	2,124,000	0
Amortization of debt discount and deferred costs	49,251,000	1,231,000	48,000
Deferred income tax benefit	(7,171,000)	0	0
Loss (gain) on change in value of derivative warrant liability	(7,821,000)	15,685,000	(1,639,000)
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(27,183,000)	(821,000)	1,984,000
Inventory	2,586,000	(3,997,000)	2,705,000
Prepaid expenses	(26,724,000)	(1,615,000)	53,000
Accounts payable	10,850,000	1,054,000	2,884,000
Accrued expenses	77,647,000	2,551,000	(2,992,000)
Other assets	56,000	(48,000)	(868,000)
Net cash provided by (used in) operating activities from continuing operations	70,809,000	(5,599,000)	(3,691,000)
Cash flows from investing activities
Internally developed or purchased software	(149,000)	0	(50,000)
Deposit for refinery purchase and related costs	0	(13,663,000)	0
Redemption of noncontrolling entity	556,000	0	0
Proceeds from the sale of assets	395,000	75,000	75,000
Acquisition of business, net of cash	(227,525,000)	2,000	(1,822,000)
Purchase of fixed assets	(75,512,000)	(2,331,000)	(5,550,000)
Net cash used in investing activities from continuing operations	(302,235,000)	(15,917,000)	(7,347,000)
Cash flows from financing activities
Line of credit payments, net	0	(133,000)	(3,143,000)
Proceeds received from exercise options and warrants	730,000	6,921,000	0
Net borrowings on inventory financing agreements	117,189,000	0	0
Contribution received from stockholder	0	2,000	0
Distribution to non-controlling interest	(380,000)	(169,000)	0
Contribution received from redeemable noncontrolling interest	0	0	21,000,000
Redemption of redeemable noncontrolling interest	(50,666,000)	0	0
Payments on finance leases	(819,000)	(844,000)	(403,000)
Proceeds from issuance of notes payable	173,256,000	143,831,000	8,217,000
Payments made on notes payable	(18,948,000)	(15,836,000)	(10,367,000)
Net cash provided by financing activities from continuing operations	220,362,000	133,772,000	15,304,000
Discontinued operations:
Net cash provided by operating activities	25,287,000	15,349,000	3,675,000
Net cash used in investing activities	(4,663,000)	(1,973,000)	(1,146,000)
Net cash used in financing activities	0	0	0
Net cash provided by discontinued operations	20,624,000	13,376,000	2,529,000
Net change in cash and cash equivalents and restricted cash	9,560,000	125,632,000	6,795,000
Cash and cash equivalents and restricted cash at beginning of the year	136,627,000	10,995,000	4,200,000
Cash and cash equivalents and restricted cash at end of year	146,187,000	136,627,000	10,995,000
Cash and cash equivalents	141,258,000	36,130,000	10,895,000
Restricted cash	4,929,000	100,497,000	100,000
Cash and cash equivalents and restricted cash as shown in the consolidated statements of cash flows	146,187,000	136,627,000	10,995,000
SUPPLEMENTAL INFORMATION
Cash paid for interest	33,901,000	2,273,000	1,051,000
Cash paid for income taxes	0	0	0
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Dividends on Series B and B-1 Preferred Stock	0	(258,000)	1,903,000
Initial carrying amount of non-controlling interest	0	0	9,091,000
Accretion of discount on Series B and B-1 Preferred Stock	0	507,000	1,688,000
Accretion of redeemable noncontrolling interest to redemption value	428,000	1,992,000	15,135,000
Equipment acquired under capital leases standard	46,351,000	552,000	1,018,000
Equipment acquired under operating leases standard	20,452,000	89,000	0
Reclass derivative liabilities	78,789,000	0	0
Conversion of Senior note	59,822,000	0	0
Series B and B-1 Preferred Stock
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Conversion of Series B and B1 Preferred Stock into common stock	$ 0	$ 24,610,000	$ 3,368,000